Summary. Using an in vitro system of pig Leydig cells (LC) and Sertoli cells (SC) we have demonstrated that: 1 ) LC contained specific receptors for both somatomedin -C/insulin-like growth factor I (Sm-C/IGF-I) and insulin, whereas SC contained only Sm-C/IGF-I receptors ; 2) pretreatment of LC with insulin or Sm-C/IGF-I increased hCG receptor number and the cAM P and testosterone responses to this hormone. The enhanced steroidogenic capacity was related to an increased activity of several enzymes of the steroidogenic pathway. At physiological concentrations Sm-C/IGF-I was more potent than insulin, but the effects of the latter peptide at micromolar concentrations were similar to those produced by nanomolar concentrations of Sm-C/IGF-I. However, at maximal concentrations of both peptides, there was no additive effect ; 3) the specificity of the effect of Sm-C/IGF-I was proven by the fact that all the effects induced by this peptide, but not by insulin, were blunted by an anti-Sm-C/IGF-I antibody ; 4) pretreatment of SC with Sm-C/IGF-I at nM concentrations or with insulin (but only at uM concentrations) enhanced the stimulatory effect of FSH on cAMP production and the secretion of plasminogen activator; 5) in both LH and SC, Sm-C/IGF-I had small mitogenic effects but potentiated the mitogenic action of fibroblast growth factor (FGF) . The effect of insulin was observed only at 11M concentrations; 6) SC secreted a factor which had physicochemical and biological properties similar to that of Sm-C/IGF-I. The secretion of this factor was stimulated by FGF and EGF. Introduction.
It has been traditional to consider that the two principal testicular functions, androgen secretion and spermatogenesis, are mainly under the control of pituitary hormones. While it is clear that gonadotropins are absolutely required for the initiation and maintenance of testicular functions, recent data indicate that in addition to this endocrine regulation, other hormones and factors, coming from the blood or secreted locally, might also participate in the regulation of testicular function (reviews : Sharpe, 1984 Sharpe, , 1986 Saez and Benahmed, 1985 ; Saez et al., 1987) .
The role of two hormones, insulin and growth hormone (GH), on testicular functions has long been suspected. Clinically, diabetes mellitus often results in disturbances in male reproductive function (Rodriguez-Rigau, 1980 ; Cameron et a/., 1985) and experimentally-induced diabetes in male rats produces a marked decrease in testicular luteotropin (LH) receptors and in Leydig cell steroidogenesis, alterations corrected by insulin treatment (Charreau et al., 1978 ; Paz and Homonnai, 1979; Murray et al., 1981) . However, given the concomitant hypogonadotropism of diabetic rats (Adashi et al., 1981 ; Murray etal., 1981) and that insulin is an absolute requirement for the maintenance of normal plasma levels of somatomedin-C/Insulin-like growth factor I (Sm-C/IGF-I) (Maes etal., 1986) Hughes et al., 1985) , it is likely that the action of GH on Leydig cell function may be mediated by Sm-C/IGF-I.
The present study concentrates mainly on recent work by our group on the characterization of somatomedin-C/insulin-like growth factor type I (Sm-C/IGF-I) and insulin receptors in somatic testicular cells and on the biological role of both peptides in Leydig and Sertoli cell functions using an in vitro system. In addition, the characterization and regulation of a Sertoli cell-secreted Sm-C-like peptide is presented. (Chernausek et al., 1985) .
Binding of 125 1 -hCG and 125 1-hFSH to the cells was used to assess the number of LH and FSH receptors, respectively, as described elsewhere (Bernier et al., 1 986b ; Saez and Jaillard, 1986) . To assess the number of insulin or the Sm-C/IGF-I receptors, cells were incubated in F-12/DME medium containing 0.5% BSA, 0.1 % bacitracin and ' 25 1-Sm-C or 125 1 -insulin (= 10-15 x 10° cpm/ml) and increasing concentrations of the corresponding unlabelled peptide at 20 °C for 4 h. At the end of the incubation, the cells were washed, solubilized in 0.4 % deoxycholate, 0.5 N NaOH and counted.
Affinity cross-liking was performed by a modification of the method described by Pilch and Czech (1980) . Cells were incubated with 125 1-insulin or 125 1 _ Sm -C 1.5 X 10 6 cpm/ml) for 4 h at 20 °C. The medium was removed, the cells washed and incubated in fresh medium containing 1 mM disuccinimidyl suberate for 15 min at 4 °C. After addition of 0.1 ml of (100 mM) Tris-HCI, 10 mM EDTA to stop the reaction, the medium was removed, the cells washed and solubilized in 0.2 ml (0.1 M) Tris-HCI pH 7, 2 % sodium dodecyl sulfate buffer, 0.001 % bromophenol blue, 100 mM dithiothreitol and run on 0.1 % sodium dodecyl sulfate/7.5 % polyacrylamide gels.
Purification of Sm-CIIGF-1-like material from Sertoli cell-conditioned medium.
After 2 days in culture, the medium was removed, the cells washed three times with saline and cultured in fresh medium containing FGF (50 ng/ml) and 3 H-leucine (20 N Ci/ml). After two days the medium was removed, acidified with acetic acid to a final concentration of 1 M and filtered (2 ml/min) through a Sep-Pak cartridge (Waters). Elution was performed with 2 ml of pure methanol and the eluate was lyophilized. The recovery of this step, monitored with 125 1-S m -C tracer, was higher than 80 %. The dry residue was suspended in 2 ml of 50 mM phosphate buffer, pH 7.4, and loaded on a 3-ml affinity chromatography column of mouse monoclonal anti-Sm-C/IGF-I and eluted as previously described (Chernausek et al., 1985) . The fractions containing the peak of Sm-C/IGF-I-like material were pooled and dialyzed against 100 volumes of 0.01 %, trifluoro-acetic acid (TFA) for 6 h and then lyophilized. The dried sample was redissolved in 500 N I of 0.1 % TFA and injected into an HPLC u-Bondapak C18 column (Waters) equilibrated with 20 % acetonitrile in 0.1 % TFA. Elution was performed with a 20 % to 60 % acetonitrile isocratic gradient in 0.1 % TFA, in 40 min.
A sample of the pooled fractions (30 to 32) of H PLC elution containing immunoreactive 3 H-leucine-Sm-C/IGF-I-like material was lyophilized and diluted in PBS, 10 % SDS, 10 % glycerol, 3 % 2-mercaptoethanol and treated at 100 °C for 3 min before running on 0.1 % SDS, 6 M urea, 18 % polyacrylamide gel. The gels were stained with silver nitrate, dried and exposed to Kodak films.
Sm-C/IGF-I content of fresh conditioned medium and of the different fractions during the purification procedure was determined by radioimmunoassay by the method previously reported (Chatelain et al., 1983 (fig. 2) . Under reducing conditions, 125 1 -Sm-C/IGF-I and ' 25 1-insulin were cross-linked predominantly to a receptor complex with an apparent Mr -125,000 similar to the a-subunit of Sm-C/IGF-I and insulin receptor observed in other studies (Rechler and Nissley, 1985; Czech, 1985) . Unlabeled Sm-C/IGF-I (200 ng/ml) and high concentrations of insulin (30 pg/ml) (data not shown) inhibited the affinity labeling of Sm-C/IGF-I receptor, whereas insulin at low concentrations (200 ng/ml) had no effect. Similarly, the affinity labeling of insulin receptors was inhibited by unlabeled insulin, but not by Sm-C/IGF-I at identical concentrations.
Specific receptors for Sm-C/IG F-I were also demonstrated in pig Sertoli cells by binding ( fig. 3 ) and cross-linking experiments (Perrard-Sapori et al., 1987a (fig. 5) ; b) pregnenolone production, under conditions where the metabolism of this steroid was blocked, was higher in Sm-C/IGF-I-or insulin-pretreated cells than in control cells (fig. 6) ; c) the conversion of exogenous pregnenolone to testosterone was also significantly higher in peptide-pretreated cells than in control cells ( fig. 6 ). These results suggest that both peptides enhanced the availability of cholesterol for steroidogenesis and/or the activity of the cholesterol side-chain cleavage and also the activity of some enzyme between pregnenolone and testosterone.
The specificity of the potentiating effects of Sm-C/IGF-I on Leydig cell function was proven by the fact that the effects were blunted when Leydig cells were treated simultaneously with Sm-C/IGF-I and an anti-Sm-C-antibody at a concentration which bound at least 95 % of the Sm-C/IGF-I ( fig. 5 and 6 ). On the contrary, the antibodies had no effect on the stimulatory effects induced by insulin. (Saez and Jaillard, 1986) . Table 2 insulin nor Sm-C/IGF-I alone or together with FGF had a significant effect on this parameter. FGF was also the only factor which enhanced cAMP response to pFSH. However, pretreatment with FGF plus Sm-C/IGF-I (50 ng/ml) or insulin at 5 pg/ml, but not at 50 ng/ml, further enhanced cAM P response to pFSH. Under basal conditions, plasminogen activator activity was very low but pretreatment with FGF, Sm-C/IGF-I (50 ng/ml) or insulin (at 5 pg/ml but not at 50 ng/ml) produced a small but significant increase (p < 0.05) (data not shown).
The response to pFSH was enhanced by previous treatment with Sm-C/IGF-I, I, insulin (5 pg/ml) and FG F, but again FG F was several times more potent than the other two factors. Both Sm-C/IGF-I (50 ng/ml) and insulin at 5 pg/ml, but not at 50 ng/ml, potentiated the effect of FG F. Sm-C/IGF-I radioimmuno-and radioreceptor-assays .
Furthermore, it migrated in polyacrylamide gel electrophoresis to the same position as both purified human Sm-C/IGF-I and recombinant DNA Sm-C/IGF-I I .
The secretion of Sm-C/IGF-I-like material by Sertoli cells was studied under several culture conditions. Sertoli cells cultured in plastic dishes secreted Sm-C/IGF-I, but this secretion fell steadily after the first two days of culture. Under our experimental conditions the only factor able to stimulate its secretion was FGF . When the cells were cultured in extracellular matrices, they became more sensitive to the stimulatory effects of FG F or EG F, but neither hGH nor FSH was able to stimulate significantly Sm-C/IGF-I secretion ( fig. 8) (Lin et al., 1986a, b) in rat Leydig cells. The presence of Sm-C/IGF-I receptors in immature rat Sertoli cells has also been reported (Borland et al., 1984 ; Oonk and Grootegoed, 1987a,b) , but contradictory results were obtained concerning insulin receptors. Borland et al. (1984) could not demonstrate such receptors in immature cultured rat Sertoli cells and in that model insulin at nanomolar concentrations had no biological effect. In contrast, Oonk et al. (1985, 1987a, 1987b) reported the presence of insulin receptors of high affinity in immature rat Sertoli cells ; these receptors had very low capacity characterized by binding and cross-linking experiments. They also showed that insulin at nanomolar concentrations was able to stimulate glucose metabolism.
In the present study both Sm-C/IGF-I (at nanomolar concentrations) and insulin (at micromolar concentrations, but not at nanomolar concentrations), had a small but significant mitogenic action on both Leydig and Sertoli cells. These results suggest that the growth stimulatory effect of insulin on testicular cells, as in other cell models (Froesch et al., 1985) , was mediated through Sm-C/IGF type I receptors. Our results also suggest that all the metabolic effects of insulin on pig Sertoli cells are exerted through Sm-C/IGF type I receptors.
The most interesting findings from the present study are the effects of (Veldhuis and Furlanetto, 1985 ; Adashi et al., 1986) and this peptide at nanomolar concentrations exerts potent and specific differentiating effects on swine granulosa cell steroidogenesis (Veldhuis and Furlanetto, 1985 ; Veldhuis and Rodgers, 1987) and synergizes with FSH in the induction of rat granulosa LH receptors, progestin and estrogen synthesis (Adashi et al., 1985) . Similarly, bovine adrenal cells contain specific Sm-C/IGF-I receptors, and this peptide at nanomolar concentration increases the number of angiotensin-11 receptors and the steroidogenic response to both angiotensin-II and ACTH (Penhoat et al., 1988) . Moreover, in both cell types, insulin at higher concentrations produces similar effects.
In both rat (Borland etal., 1984 ; Mita etal., 1985 ; Oonk etal., 1987a, b) and pig (Jaillard et al., 1987, present (Hammond et al., 1985; Hsu and Hammond, 1987) and rat (Davoren and Hsueh, 1986 ) granulosa cells and their purtative male homolog, Sertoli cells from the same species (Ritzen, 1983 ; Tres et al., 1986 ; Smith et al., 1987 ; IChatelain etal., 1987) , secrete Sm-C/IGF-I immunoreactivity in the medium. The Sm-C/IGF-I-like peptide purified from rat (Smith etal., 1987) The physiological in vivo significance of the endocrine/paracrine/autocrine role of Sm-C/IGF-I on testicular growth and functions is suggested by the fact that in both humans (Tanner et al., 1975 ; Kulin et al., 1981 ; Laron, 1984) Les LC contiennent des récepteurs spécifiques pour la Sm-C/IGF-1 et pour l'insuline, tandis que les SC contiennent seulement des récepteurs pour la Sm-C/IGF-1. 2) La Sm-C/IGF-1 et l'insuline augmentent le nombre de récepteurs à l'hCG et la réponse (AMPc et testostérone) à cette hormone des LC. A concentrations physiologiques (nM) la Sm-C/IGF-1 est plus efficace que l'insuline, mais les effets de l'insuline à concentrations micromolaires sont similaires à ceux induits par la Sm-C/IGF-1 à des concentrations nanomolaires. Par ailleurs, à des concentrations maximales, les effets des deux peptides ne sont pas additifs. 3) Les effets de la Sm-C/IGF-1, mais pas ceux de l'insuline, sur les LC sont bloqués par un anticorps anti-Sm-C/IGF-I. 4) Le traitement des SC avec la Sm-C/IGF-1 (nM) ou avec l'insuline (pM) augmente l'action stimulante de la FSH sur la production d'AM Pc et sur la sécrétion de l'activateur du plasminogène. 5) La Sm-C/IG F-I a une faible action mitogène sur les deux types de cellules, mais le peptide potentialise l'action mitogène du facteur de croissance fibroblastique (FGF). 6) Les SC sécrètent un facteur qui a les caractéristiques physico-chimiques et biologiques de la Sm-C/IGF-1 et cette sécrétion est stimulée par le FGF seul ou associé à la FSH. L'ensemble de ces résultats suggère fortement que la Sm-C/IGF-1 peut jouer un rôle autocrine et paracrine dans l'expression et le maintien des fonctions différenciées des cellules somatiques testiculaires.
